BioSpace News Archive

Nkarta, Inc., a clinical-stage biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced the pricing of its initial public offering of 14,000,000 shares of common stock at a public offering price of $18.00 per share.

MilliporeSigma opened its M Lab™ Collaboration Center in Shanghai, the company’s largest of nine centers worldwide.

Sedana Medical AB announced a positive top line result for the company’s pivotal phase III study, IsoConDa.

Atox Bio announced results from the randomized, double-blind, placebo-controlled Phase 3 ACCUTE trial of reltecimod for the early treatment of severe Necrotizing Soft Tissue Infection.

Transparency Market Research has published a new report titled, ‘Wound Debridement Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to the report, the global women’s health diagnostics market was valued at ~US$ 30.7 Bn in 2018 and is projected to expand at a CAGR of ~6% from 2019 to 2027. Rise in prevalence of menopause, favorable incentive and reimbursement policies for UTIs, and technical advancements are anticipated to augment the global market from 2019 to 2027.

According to the report, the global warts therapeutics market was valued at US$ 1.7 Bn in 2019.

The demand within the global von Willebrand disease treatment market is rising at a boisterous pace in recent times.

Transparency Market Research has published a new report titled traveler’s diarrhea treatment market.

Transparency Market Research has published a new report on the pseudomonas aeruginosa infection treatment market for the forecast period of 2019–2027. According to the report, the global pseudomonas aeruginosa infection treatment market was valued at ~US$ 1 Bn in 2018, and is projected to expand at a CAGR of ~6% from 2019 to 2027.